CompletedPhase 2NCT02315898
Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis
Studying Plastic bronchitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Michigan
- Principal Investigator
- Kathleen A Stringer, PharmDUniversity of Michigan
- Intervention
- Treatment-inhaled tPA(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 5-24 years · All sexes
- Timeline
- 2018 – 2023
Study locations (6)
- Lucile Packard Children's Hospital, Stanford University, Palo Alto, California, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- University of Michigan Mott Children's Hospital, Ann Arbor, Michigan, United States
- Cincinnati Children's Hospital, Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Medical University of South Caroline, Charleston, South Carolina, United States
Collaborators
Genentech, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02315898 on ClinicalTrials.gov